Gastroenterology Doctors in Sun City, AZ Accepting Medicare

3 Gastroenterology doctors found. Showing 1 - 3

Dr. Yvette Lam-tsai, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 13640 N 99th Ave, Ste 600, Sun City, AZ 85351 Phone: 623-972-2116    Fax: 623-972-0521

Dr. Ramkrishna Kothur, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 13640 N 99th Ave Ste 600, Sun City, AZ 85351 Phone: 623-972-2116    Fax: 623-972-0521

David Winston, M.D. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 13041 N Del Webb Blvd, Sun City, AZ 85351 Phone: 623-977-7201

News Archive

Potential new intraocular treatment based on RAS manipulation can prevent or reverse diabetic retinopathy

Pathologic changes of the retina caused by diabetes is the leading cause of blindness in working adults. Diabetic retinopathy has no known cure, treatment options are inadequate, and prevention strategies offer limited protection. In the first of its kind, a report in The American Journal of Pathology describes a potential new intraocular treatment based on manipulating the renin angiotensin system (RAS) that both prevents and reverses some characteristics of diabetic retinopathy in a mouse model.

Higher 36°C temperature as effective as 33°C for therapeutic hypothermia treatment

Therapeutic hypothermia - cooling the body and brain down to 33-C - is the method used worldwide to treat cardiac arrest, even though a lower body temperature may raise the risk of side-effects. However, keeping the temperature steady at 36-C is just as effective, a study led by Lund University researchers has found.

Surgical biopsies can be safely performed on selected patients with late-stage lung cancer

Researchers at UC Davis have determined that surgical biopsies can be safely performed on select patients with late-stage non-small cell lung cancer, which should enhance their access to drugs that target specific genetic mutations such as epidermal growth factor receptor (EGFR).

GlycoVaxyn initiates Phase I clinical study of GVXN SD133 vaccine candidate against Shigella dysenteriae

GlycoVaxyn, a pioneer in the development of innovative bioconjugate vaccines, has commenced a Phase I clinical study with its vaccine candidate (GVXN SD133) against Shigella dysenteriae, a cause of serious intestinal infections. This is the first product from the company to enter clinical evaluation.

The relationship between pain and age related disability

Younger people with pain look similar in terms of their disability to people who are two to three decades older without pain, according to a study published in this month's issue of the Journal of the American Geriatric Society. The results of the study uncovered that people with pain develop the functional limitations classically associated with aging at much earlier ages.

Read more Medical News

› Verified 9 days ago